MedPath

Investigation for safety and efficacy of a new antiseptic Olanexidine Gluconate in childre

Not Applicable
Conditions
Patients who undergo surgery of catheter insertion or inguinal hernia
Registration Number
JPRN-UMIN000027899
Lead Sponsor
ational Center for Child Health and Development
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
55
Inclusion Criteria

Not provided

Exclusion Criteria

(1)History of drug sensitivity. (2)History of shock or hypersensitivity against Chlorhexidine gluconate. (3)Patients having cutaneous disease (4)Any patients who was judged as inappropriate candidate to enroll this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome was determined to assess the rate of any adverse effect such as labo data, vital sign, subjective and objective symptom, erythema or irritation of the skin.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath